La catena delle opzioni mostra i dati chiave delle opzioni azionarie di GIBO Holdings a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per GIBO Holdings..

GIBO Holdings (NASDAQ:GIBO) Azioni, Catena delle Opzioni

GIBO Holdings Ltd, along with its subsidiaries is focused on revolutionizing content creation and consumption through AI. The company acts as a integrated AIGC animation streaming platform with extensive functionalities provided to both viewers and creators that serves a broad community of young people across Asia to create, publish, share and enjoy AI-generated animation video content.

Wall-street-shutter3

Long Ideas

News

Markets

Trading Ideas

EPWK

GIBO

HUYA

Tre titoli del settore comunicazione sono crollati fino al 96%. Un segnale tecnico suggerisce che potrebbero essere sottovalutati.

3 azioni tech che un indicatore segnala come &#34;da comprare&#34;

GIBO Holdings Limited - Class A Ordinary Shares

GIBO Holdings Ltd

Barclays analyst Benjamin Budish maintains Blue Owl Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWL#NYSE">OWL</a>) with a Overweight and raises the price target from $21 to $23.

Price Target

Analyst Ratings

Barclays Maintains Overweight on Blue Owl Capital, Raises Price Target to $23

Morgan Stanley analyst Terence Flynn maintains Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) with a Underweight and lowers the price target from $36 to $34.

Morgan Stanley Maintains Underweight on Bristol-Myers Squibb, Lowers Price Target to $34

Barclays analyst Benjamin Budish maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Equal-Weight and raises the price target from $136 to $168.

Barclays Maintains Equal-Weight on Blackstone, Raises Price Target to $168

Morgan Stanley analyst Matthew Harrison maintains Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) with a Overweight and lowers the price target from $755 to $754.

REGN

Morgan Stanley Maintains Overweight on Regeneron Pharmaceuticals, Lowers Price Target to $754

Barclays analyst Benjamin Budish maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Overweight and raises the price target from $990 to $1220.

Barclays Maintains Overweight on BlackRock, Raises Price Target to $1220

Morgan Stanley analyst Matthew Harrison maintains Legend Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEGN#NASDAQ">LEGN</a>) with a Overweight and raises the price target from $80 to $81.

LEGN

Morgan Stanley Maintains Overweight on Legend Biotech, Raises Price Target to $81

Barclays analyst Nicholas Campanella maintains Atmos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATO#NYSE">ATO</a>) with a Equal-Weight and lowers the price target from $156 to $153.

Barclays Maintains Equal-Weight on Atmos Energy, Lowers Price Target to $153

XRP's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) has broken above $2.39 for the first time since May 23, buoyed by growing whale accumulation and bullish momentum around Ripple's ecosystem. 
Market watchers now see signs of <a href="https://www.benzinga.com/money/ripple-xrp-price-prediction">an imminent breakout.</a>
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Ticker</td>
<td>Price</td>
<td>Market Cap</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>XRP</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.44</td>
<td>&nbsp;$144.4 billion</td>
<td>+7.8%</td>
</tr>
<tr>
<td>Bitcoin</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$111,368.12</td>
<td>&nbsp;$2.2 trillion</td>
<td>+1.6%&nbsp;</td>
</tr>
<tr>
<td>Ethereum</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,771.92</td>
<td>&nbsp;$335.1 billion</td>
<td>+7.4%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Cryptoinsightuk <a href="https://x.com/Cryptoinsightuk/status/1943233384819425509">noted</a> that XRP has cleared a key resistance level and is now holding it as hourly support. 
While yesterday's close hinted at bullish continuation, he says a strong close today would confirm a full-blown rally. Similar breakouts in the past have led to explosive moves, signaling what he calls potential "fireworks ahead."
Oscar Ramos, <a href="https://x.com/thecryptobasic/status/1943298136878772542">quoted </a>by Crypto Basic, is urging investors to go &#8220;all-in&#8221; on XRP, calling it a &#8220;must-have&#8221; in bullish portfolios. With Bitcoin hitting new highs at $112,000, altcoins like XRP are following with renewed strength. Ripple's progress with its RLUSD stablecoin and utility expansion is helping drive the sentiment shift.
Statistics: Santiment <a href="https://x.com/santimentfeed/status/1943017401009713342">data</a> shows XRP has reached a 7-week high, surpassing $2.39 for the first time since May 23. 
Whale activity is increasing, with 2,742 wallets now holding at least 1 million XRP, just one short of the all-time high. These large holders now control 47.32 billion XRP, signaling strong confidence in the asset's future.
Coinglass data shows XRP open interest increased 3.9% in a single day while derivatives trading volume expanded by 20.3%. 
Short liquidations of $7.97 million in the past 24 hours, continue to rise for the second consecutive day, implying traders forced to close their positions in the wake of XRP's rally.
Community News: Ripple <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46323539/xrp-boosted-4-by-ripples-stablecoin-partnership-with-bny-mellon">announced</a> that BNY, America's oldest running bank, will act as primary custodian for reserves backing its RLUSD stablecoin. The move aims to accelerate institutional trust and adoption.
Ripple is also actively pursuing a national bank charter and Federal Reserve master account to further legitimize RLUSD, which now <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46318111/xrp-eyes-2-40-as-ripples-rlusd-stablecoin-smashes-500m-market-cap">boasts </a>a more than $500 million market cap, making it the eighth-largest stablecoin after surpassing TrueUSD.
CEO Brad Garlinghouse reiterated that XRP's regulatory clarity is now well established, calling this a green light for broader adoption and use.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46327959/xrp-spikes-3-is-a-breakout-imminent">XRP Spikes 3%: Is A Breakout Imminent?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

XRP Breaks Above $2.40 For First Time Since May: How High Can It Go?

Morgan Stanley analyst Terence Flynn maintains BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) with a Overweight and raises the price target from $132 to $133.

BNTX

Morgan Stanley Maintains Overweight on BioNTech, Raises Price Target to $133

Morgan Stanley analyst Terence Flynn maintains Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) with a Overweight and raises the price target from $1133 to $1135.

Morgan Stanley Maintains Overweight on Eli Lilly, Raises Price Target to $1135

Barclays analyst Benjamin Budish maintains Ares Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) with a Overweight and raises the price target from $182 to $200.

ARES

Barclays Maintains Overweight on Ares Management, Raises Price Target to $200

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NASDAQ">UTHR</a>) with a Equal-Weight and lowers the price target from $348 to $328.

UTHR

Morgan Stanley Maintains Equal-Weight on United Therapeutics, Lowers Price Target to $328

Morgan Stanley analyst Betsy Graseck maintains Ally Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>) with a Overweight and raises the price target from $39 to $47.

ALLY

Morgan Stanley Maintains Overweight on Ally Financial, Raises Price Target to $47

Barclays analyst Benjamin Budish maintains Apollo Asset Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) with a Overweight and raises the price target from $156 to $168.

Barclays Maintains Overweight on Apollo Asset Management, Raises Price Target to $168

Morgan Stanley analyst Betsy Graseck maintains American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) with a Equal-Weight and raises the price target from $250 to $311.

Morgan Stanley Maintains Equal-Weight on American Express, Raises Price Target to $311

Barclays analyst Eric Beaumont maintains American Water Works Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>) with a Underweight and lowers the price target from $138 to $128.

Barclays Maintains Underweight on American Water Works Co, Lowers Price Target to $128

Barclays analyst Brandon Oglenski maintains American Airlines Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) with a Equal-Weight and raises the price target from $11 to $12.

Barclays Maintains Equal-Weight on American Airlines Group, Raises Price Target to $12

<a href="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_07102025_SNGX_Bautz.pdf" title="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_07102025_SNGX_Bautz.pdf">https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_07102025_SNGX_Bautz.pdf</a>

SNGX

Watching Soligenix; Zacks Small-Cap Research Gives Stock $35 Price Valuation

Barclays analyst Nicholas Campanella maintains Ameren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEE#NYSE">AEE</a>) with a Equal-Weight and lowers the price target from $104 to $100.

Barclays Maintains Equal-Weight on Ameren, Lowers Price Target to $100

B of A Securities analyst Bryan Spillane reinstates Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Buy and announces $110 price target.

Initiation

B of A Securities Reinstates Buy on Estee Lauder Cos, Announces $110 Price Target

Fintech

Press Releases

GIBO Announces Kickstart of USDG Wallet Initiative: Building the Next Generation of Multi-Currency Digital Asset Management

GIBO Announces Upcoming Launch of GIBO Create-to-Earn Module to Empower Monetization of AI Animation and Creative Content within Its Ecosystem

GIBO Click Empowers 72 Million Users to Create AI-Avatars, Advancing the Future of Intelligent Figurine Identities

Entertainment

General

GIBO Click Empowers 72 Million Users to Create AI-Avatars, Advancing the Future of Intelligent Figurine Identities and Real-World Asset Integration

GIBO Introduces AIARSE: AI Asset Recognition & Settlement Engine to Automate Creator Monetization and IP Value Distribution

GIBO Announces Successful Application of inspirAI in Short Drama, Completes Thematic Creation Tests with HoneyReels, Pioneering Cross-Format Innovation in Anime and Live-Action Short Drama

GIBO Launches SparkRWA: A Dual-Purpose Platform for Tokenizing Narrative IP and Verifying Real-World Creative Assets

Small Cap

GIBO Successfully Tests USDG.net Engine for Multi-Crypto Payments Across GIBO Click Ecosystem and WeChat Short Drama Platforms

GIBO Click Achieves Another Milestone with YouShort Trial: Advancing Multi-Currency Settlement and Audience Intelligence for Short Drama Platforms

GIBO Click Powers Intelligent Monetization Trials on uDrama, Enhancing Multicurrency Transactions and Viewer Insights

Antelope Enterprise Holdings Limited - Class A Ordinary Shares

Antelope Ent Hldgs

BuzzFeed

Cheer Holding, Inc. - Class A Ordinary Share

Cheer Holding

DHI Group

Fangdd Network Group Ltd. - Class A Ordinary Shares

Fangdd Network Group

Phoenix New Media Limited American Depositary Shares, each representing 48 Class A ordinary shares.

Comments

GIBO Holdings

GIBO Holdings (GIBO) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO